Molecular analysis of Arabidopsis mutants displaying hypocotyl elongation defects in both the dark and light revealed recently that steroids play an essential role as hormones in plants. De¢ciencies in brassinosteroid biosynthesis and signalling permit photomorphogenic development and light-regulated gene expression in the dark, and result in severe dwar¢sm, male sterility and de-repression of stress-induced genes in the light. A cytochrome P450 steroid hydroxylase (CYP90) controls a rate limiting step in brassinosteroid biosynthesis and appears to function as a signalling factor in stress responses. Another key step in steroid biosynthesis is controlled by the Arabidopsis SNF1 kinases that phosphorylate the 3-hydroxy3methylglutaryl-CoA reductase. The activity of SNF1 kinases is regulated by PRL1, an evolutionarily conserved a-importin-binding nuclear WD-protein. The prl1 mutation results in cell elongation defects, de-repression of numerous stress-induced genes, and augments the sensitivity of plants to glucose, cold stress and several hormones, including cytokinin, ethylene, auxin, and abscisic acid.
Hypocotyl elongation of seedlings during skotomorphogenesis in the dark is inhibited by light signals perceived by the photoreceptor phytochrome A (phyA) controlling the onset of photomorphogenesis and de-etiolation (Mustilli & Bowler 1997) . As for light signals, ethylene also inhibits hypocotyl elongation in the dark, but prevents the opening of apical hook of cotyledons (Ecker 1995) . Induction of photomorphogenesis by phyA-activation is repressed by glucose signalling (Barnes et al. 1996) involving the functions of, as yet, unknown SUN genes (Dijkwel et al. 1997) . Mutations in the DET (de-etiolated) and COP (constitutive photomorphogenesis) genes induce photomorphogenesis in the dark (Chory et al. 1996) . The DET and COP functions act downstream of the photoreceptors and their absence results in the activation of light-induced genes, as well as genes involved in general stress responses (von Armin & Deng 1996; Mayer et al. 1996) . The DET^COP functions also seem to a¡ect cytokinin signalling. For example, cytokinin signalling enhances, synergistically, the light-induced onset of photomorphogenesis, and cytokinins phenocopy the det1 mutation (Chory et al. 1994) . In the dark, the COP1 WDprotein and DET1 are located in the nucleus and probably function as general repressors of light-regulated genes. COP1 and DET1 act in concert with elements of the COP9 complex that shows a similarity to chromatin remodelling modulator complexes of RNA polymerase II (Chamovitz et al. 1996; Wilson et al. 1996) .
Whereas the DET1 and COP functions are needed for safe-guarding the light-and stress-regulated pathways in the dark, the DET2, CPD1 (constitutive photomorphogenic dwarf ), DIM1 (diminuto), and BRI1 (brassinosteroid insensitivity) genes are required for positive control of skotomorphogenesis. DET2, DIM1, and CPD1 code for enzymes involved in the biosynthesis of plant steroid hormones, termed brassinosteroids (BRs) (Sakurai & Fujioka 1997; Yokota 1997) , whereas BRI1 is required for BR-perception . Mutations a¡ecting BR biosynthesis and signalling result in the inhibition of hypocotyl elongation in the dark, and cause severe dwar¢sm in light-grown plants. DET2 is a 5a-steroid reductase that is required for the production of campestanol by catalysing the synthesis of (24R)-24-methyl-5a-cholestan-3-one from (24R)-24-methylcholestan-4-en-3-one. DET2 mediates also the conversion of progesterone, teasterone, and androstendione to their 5a-reduced forms in animal cells. Similarly, animal 5a-steroid reductases can complement the Arabidopsis det2 mutation, indicating a remarkable conservation of functions in plant and animal steroid biosynthesis . Our studies show that the CPD gene codes for a cytochrome P450 enzyme (CYP90) involved in C23-hydroxylation of cathasterone to teasterone, whereas DIM1 is probably involved in the biosynthesis of typhasterol (Szekeres et al. 1996) .
SIGNALLING FUNCTION OF CYP90 IN BRASSINOSTEROID BIOSYNTHESIS
Complete loss of the CPD function results in the derepression of light regulated-genes (e.g. RBCS and CAB) in the dark, as well as activation of a set of stress-regulated genes (e.g. chalcone synthase, lipoxygenase, alcohol dehydrogenase and so on) in the light. This indicates that brassinosteroids are not only required for stimulation of cell elongation by controlling the activity of genes involved in cell wall biosynthesis (Clouse 1996) , but also exert a negative control over several pathways regulated by stress and hormonal stimuli. Overexpression of the CYP90 steroid hydroxylase in transgenic plants induces the expression of pathogenesis-related genes independently of BR production. This suggests that CYP90 may also perform a signalling function. Recent data demonstrate that expression of the CPD gene is feedback regulated by BRs at the level of transcription. The fact that protein synthesis inhibitors, such as cycloheximide, prevent down-regulation of the CPD gene by BRs indicates that BR-mediated signalling requires de novo synthesis of a repressor (Mathur et al. 1998) . Feedback regulation of the CPD gene by BRs shows a remarkable analogy to oxysterol signalling in mammals. Oxysterols are hydroxylated cholesterol derivatives that, by analogy to BRs, down-regulate the transcription of steroid hydroxylase genes in mammals (Honda et al. 1993; Janowski et al. 1996; Lala et al. 1997) . Oxysterols inhibit the proteolytic processing of membrane-bound sterol regulatory element-binding factors (SREBPs) controlling the transcription of genes involved in steroid biosynthesis, including the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) (Brown & Goldstein 1997) . It is therefore intriguing that CYP90 has been found to interact in the yeast two-hybrid system with a sterol-binding protein, as well as with RING-¢nger factors showing homology to protease inhibitors (Z. Koncz-Ka¨lma¨n, unpublished data).
THE CPD GENE IS REGULATED BY PRL1 IN ARABIDOPSIS
By characterizing the regulation of the CPD gene in diverse Arabidopsis mutants, we have found that, as in BRs, a mutation in pleiotropic regulatory locus-1 (PRL1) down-regulates transcription of the CPD gene in lightgrown Arabidopsis plants. The PRL1 gene codes for a WD-protein that, by analogy to COP1, functions as a negative regulator of a set of light-, hormone-, and stress-regulated genes (Ne¨meth et al. 1998) . Mutation of PLR1 results in complex phenotypic defects, including the inhibition of hypocotyl elongation in the dark. Intriguingly, whereas the det1 mutation is phenocopied by cytokinin in the dark, the phenotype of the prl1 mutation is mimicked by cytokinin treatment of wildtype plants only in the light. The prl1 mutation results in hypersensitivity to glucose and sucrose, as well as transcriptional de-repression of genes that are positively or negatively regulated by glucose, or cytokinin, or both. The prl1 mutation also augments the sensitivity of seedlings to auxin, ethylene, abscisic acid, and cold temperature. As a result of these regulatory alterations, root elongation of the prl1 mutant is inhibited in both the dark and light. In addition, prl1 roots produce ectopic root hairs and show de-repressed initiation of side-root development.
PRL1 IS A CONSERVED a-IMPORTIN-BINDING NUCLEAR PROTEIN THAT FUNCTIONS AS A REGULATOR OF ARABIDOPSIS SNF1 KINASES
PRL1 encodes a basically charged protein of 54 kDa that is found in both a free cytoplasmic form and in association with microsomal (endoplasmatic reticulum and nuclear) membranes. Immunolocalization studies show that a proportion of PRL1 protein is located in the nucleus in Arabidopsis. PRL1 carries seven WD-40 repeats that share over 60% identity with PRL1 orthologues found in yeast, Caenorhabditis, Drosophila, and mouse. Recently, a PRL1 homologue (GenBank AF044333) was located on human chromosome 4q31.2. Functional conservation of PRL1 orthologues in mammals is indicated by the observation that PRL1 is also imported into the nucleus when expressed in human cells. PRL1 functions as a receptor for activated human protein kinase C in vitro (i.e. RACK, Ron & Mochly-Rosen 1995) . Speci¢c binding of PRL1 to activated protein kinase C-bII, but not to PKC-bI, suggests that PRL1 orthologues may regulate glucose signalling in mammals where di¡erential splicing, expression, and nuclear transport of PKC-bII are induced by insulin signalling (Chalfant et al. 1995) .
Genetic screening for PRL1 interacting proteins in the yeast two-hybrid system revealed that PRL1 speci¢cally binds a novel a-importin, ATHKAP2 (Ne¨meth et al. 1998 ). ATHKAP2 does not bind to proteins containing monopartite and bipartite nuclear localization signals (NLS). Thus, although a variant of the SV40-type NLS is carried by the C-terminus of PLR1, binding of ATHKAP2 to PRL1 in the yeast two-hybrid system is probably not owing to a recognition of PRL1-NLS, but rather re£ects a regulatory interaction. PRL1-binding to human PKC-bII also suggests that PRL1 may in fact serve as a protein kinase-targeting subunit involved in the control of nuclear import by either phosphorylation of NLS sequences or a-importin.
Homologues of the yeast Ser^Thr protein kinase SNF1p have also been identi¢ed as PRL1-binding proteins in the yeast two-hybrid system. In yeast, SNF1p is a master kinase in glucose signalling and its function is required for de-repression of glucose-repressible genes (reviewed by Ronne (1995) ). Yeast SNF1p controls the phosphorylation, and thereby nuclear localization, of MIG1p that acts as a repressor of glucose-regulated genes by recruiting the general transcriptional repressor complex TUP1-SSN6 (Tzamarias & Struhl 1995) . Although TUP1 is a prototype of WD-protein repressors showing functional analogy to PRL1, the tup1 mutations cannot be complemented by the Arabidopsis PRL1 cDNA. Binding of PRL1 to yeast and Arabidopsis SNF1 kinases is regulated by glucose. PRL1, as the yeast SNF1-activator SNF4, shows an enhanced binding to SNF1p in the absence of glucose, whereas the PRL1^SNF1 interaction is inhibited when yeast is grown in the presence of glucose. The fact that Arabidopsis SNF1 homologues can functionally complement the yeast snf1 mutation and suppress the snf4 de¢ciency demonstrates the conservation of SNF1 and PRL1 functions between yeast and plants.
Arabidopsis SNF1 homologues Akin10 and Akin11, similarly to other plant SNF1-kinases, are capable of phosphorylating proteins carrying the SAMS peptide motif, including HMGR (Dale et al. 1995) . Phosphorylation by SNF1 inhibits the activity of HMGR catalysing the ¢rst committed step in steroid biosynthesis. As in yeast, the activity of Akin10 and Akin11 SNF1-kinases is negatively regulated in Arabidopsis by glucose in the dark. In contrast, glucose increases the activity of SNF1 kinases in light-grown Arabidopsis seedlings, indicating a connection with light signalling. In the light, the activity of SNF1 kinases is three-to ¢vefold higher in prl1 than in wildtype plants, showing that PRL1 is a negative regulator of SNF1 kinases in light-grown plants. Abnormal activation of the SNF1 kinases thus correlates well with cell elongation defects and down-regulation of the CPD gene observed in the prl1 mutant. In the dark, the SNF1 kinase activity is lower in prl1 than in wild-type plants indicating that PRL1 is a positive modulator of SNF1 kinase in darkgrown plants (Bhalerao et al. 1998) . PRL1 inhibits in vitro the phosphorylation of SAMS peptide by both Arabidopsis Akin10 and Akin11 SNF1 kinases. Therefore, it is likely that in vivo regulation of SNF1 kinases by PRL1 involves light-, and glucose-dependent post-translational modi¢-cations, such as phosphorylation by activating kinases, and dephosphorylation by protein phosphatases. This conclusion is supported by data showing that the levels of protein phosphatase type 1 and 2a are signi¢cantly reduced in the light-grown prl1 mutant, as well as that PRL1 has been found to interact also with a speci¢c Ca 2+ -dependent kinase.
CONCLUSIONS
In this review, we aimed to give a brief insight into recent studies of novel signalling functions coordinating plant responses to metabolic, hormonal and environmental stimuli. In particular, regulatory relations (see ¢gure 1) between two seemingly unrelated signalling proteins, CYP90 in steroid biosynthesis and PRL1 in the control of glucose repression, have been discussed. Research in progress shows that the fragmentary relations described here will be soon supplemented by many more Glucose repression and steroid signalling in Arabidopsis K. Salchert and others 1519
Phil. Trans. R. Soc. Lond. B (1998) Figure 1 . Regulatory connections between glucose and steroid signalling: a model. As outlined in the text, the a-importinbinding PRL1 protein is a regulator of the SNF1 kinase, and functions as a speci¢c receptor for human protein kinase C-bII in vitro. PRL1 may target protein kinases to complexes of a and b importins and a¡ect the regulation of nuclear import by phosphorylation of nuclear localization sequences (NLS) of transcription regulatory proteins or a-importins. The CPD gene controls a rate-limiting step in BR biosynthesis. Negative feedback regulation of CPD expression by BRs requires the synthesis of a BRrepressor. The CPD gene is down-regulated in the prl1 mutant, suggesting that PRL1 controls the transcription of CPD. The PRL1 controlled SNF1 kinase down-regulates the activity of HMGR by phosphorylation and thereby may modulate the ¢rst committed step in steroid biosynthesis. The CPD gene product, CYP90, interacts in the yeast two-hybrid system with an oxysterol-binding protein and signalling factors carrying RING-¢nger motives of protease inhibitors. CYP90 may thus be part of a mechanism that, by analogy to oxysterol signalling in mammals (Brown & Goldstein 1997) , controls the activity of a membrane-bound steroid regulatory factor by, for example, proteolytic processing or phosphorylation.
partners and regulatory connections. Thus, genetic analyses suggest that the prl1 mutation is exacerbated by the amp1 function regulating cytokinin production and cell division of meristems (Chaudhury et al. 1993) . In addition, the ein2 mutation that confers cytokinin resistance and ethylene insensitivity (Ecker 1995) appears to be epistatic to prl1 in the dark, but this epistatic relation is reversed in the light (Ne¨meth et al. 1998) . Biochemical and genetic data demonstrate that PRL1 is a regulator of many diverse genes, including CPD in BR biosynthesis. CPD may also specify a signalling function, because its overexpression activates a set of pathogenesis-related genes, and because its product, the CYP90 C23-steroid hydroxylase, interacts with novel signalling proteins. Thus, CYP90 may, in fact, control a pathway of stress signalling in addition to being essential for the biosynthesis of BR hormones. PRL1 is a regulator of SNF1 kinases that control the expression of glucose-, and cytokininresponsive genes by overcoming the regulation of these genes by other signals. Analysis of the PRL1 function not only supports the notion that light, glucose, and cytokinin signalling are tightly cross-connected (Chory et al. 1996; von Armin & Deng 1996) , but also suggests a considerable conservation of eukaryotic regulatory mechanisms modulating nuclear import by protein kinases and their targeting subunits, and cross-talk between glucose and steroid signalling.
